Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Natural killer cell lymphoma in a pediatric patient with inflammatory bowel disease.

Deneau M, Wallentine J, Guthery S, O'Gorman M, Bohnsack J, Fluchel M, Bezzant J, Pohl JF.

Pediatrics. 2010 Oct;126(4):e977-81. doi: 10.1542/peds.2010-0486. Epub 2010 Sep 13.

PMID:
20837584
[PubMed - indexed for MEDLINE]
Free Article
2.

Extranodal natural killer/T-cell lymphoma, nasal-type.

Chorianopoulos D, Samitas K, Vittorakis S, Kiriazi V, Rondoyianni D, Tsaousis G, Skoutelis A.

Skinmed. 2010 Jan-Feb;8(1):56-8.

PMID:
20839428
[PubMed - indexed for MEDLINE]
4.

A case of extranodal NK/T-cell lymphoma, nasal type mimicking typical manifestations of adult-onset Still's disease (AOSD) with hemophagocytic syndrome: diagnostic consideration between malignant lymphoma without lymphadenopathy and AOSD.

Kato T, Tanabe J, Kanemoto M, Kobayashi C, Morita S, Karahashi T.

Mod Rheumatol. 2009;19(6):675-80. doi: 10.1007/s10165-009-0204-y. Epub 2009 Jul 17.

PMID:
19609486
[PubMed - indexed for MEDLINE]
5.

Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review.

Subramaniam K, D'Rozario J, Pavli P.

J Gastroenterol Hepatol. 2013 Jan;28(1):24-30. doi: 10.1111/jgh.12015. Review.

PMID:
23094824
[PubMed - indexed for MEDLINE]
6.

EBV-associated colonic B-cell lymphoma following treatment with infliximab for IBD: a new problem?

Allen PB, Laing G, Connolly A, O'Neill C.

BMJ Case Rep. 2013 Sep 30;2013. pii: bcr2013200423. doi: 10.1136/bcr-2013-200423.

PMID:
24081592
[PubMed - indexed for MEDLINE]
7.

The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series.

Sandhu A, Alameel T, Dale CH, Levstik M, Chande N.

Aliment Pharmacol Ther. 2012 Jul;36(2):159-65. doi: 10.1111/j.1365-2036.2012.05141.x. Epub 2012 May 23.

PMID:
22616981
[PubMed - indexed for MEDLINE]
8.

Serious events with infliximab in patients with inflammatory bowel disease: a 9-year cohort study in the Netherlands.

de Vries HS, van Oijen MG, de Jong DJ.

Drug Saf. 2008;31(12):1135-44. doi: 10.2165/0002018-200831120-00009.

PMID:
19026030
[PubMed - indexed for MEDLINE]
9.

Cutaneous peripheral T-cell lymphoma of cytotoxic phenotype mimicking extranodal NK/T-cell lymphoma.

Pan ST, Chang WS, Murphy M, Martinez A, Chuang SS.

Am J Dermatopathol. 2011 Apr;33(2):e17-20. doi: 10.1097/DAD.0b013e3181ea6571.

PMID:
21252637
[PubMed - indexed for MEDLINE]
10.

Infliximab therapy in children and adolescents with inflammatory bowel disease.

Veres G, Baldassano RN, Mamula P.

Drugs. 2007;67(12):1703-23. Review.

PMID:
17683171
[PubMed - indexed for MEDLINE]
11.

Safety of infliximab and other biologic agents in the inflammatory bowel diseases.

Reddy JG, Loftus EV Jr.

Gastroenterol Clin North Am. 2006 Dec;35(4):837-55. Review.

PMID:
17129816
[PubMed - indexed for MEDLINE]
12.

T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.

Isobe Y, Aritaka N, Setoguchi Y, Ito Y, Kimura H, Hamano Y, Sugimoto K, Komatsu N.

J Clin Pathol. 2012 Mar;65(3):278-82. doi: 10.1136/jclinpath-2011-200523. Epub 2012 Jan 13.

PMID:
22247563
[PubMed - indexed for MEDLINE]
13.

Adult patient with Epstein-Barr virus (EBV)-associated lymphoproliferative disorder: chronic active EBV infection or de novo extranodal natural killer (NK)/T-cell lymphoma, nasal type?

Ohtsuka R, Abe Y, Sada E, Kiyasu J, Ashikari A, Shiratsuchi M, Nishimura J, Takayanagi R, Ohshima K.

Intern Med. 2009;48(6):471-4. Epub 2009 Mar 16.

PMID:
19293549
[PubMed - indexed for MEDLINE]
Free Article
14.

A case of CD30+ nasal natural killer/T-cell lymphoma.

Ferenczi K, Summers P, Aubert P, Cooper B, Meyerson H, Cooper KD, Honda K.

Am J Dermatopathol. 2008 Dec;30(6):567-71. doi: 10.1097/DAD.0b013e318184bc3f.

PMID:
19033930
[PubMed - indexed for MEDLINE]
15.

A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.

Chang BH, Stork L, Fan G.

Pediatr Dev Pathol. 2008 Jan-Feb;11(1):50-4. doi: 10.2350/06-07-0140.1.

PMID:
18237230
[PubMed - indexed for MEDLINE]
16.

Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.

Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, Cheung MM, Lau WH.

Blood. 1997 Jun 15;89(12):4501-13. Review.

PMID:
9192774
[PubMed - indexed for MEDLINE]
Free Article
17.

[Clinicopathologic features of systemic EBV-positive T/NK-cell lymphoproliferative disease in adults].

Zheng XD, Zhou XG, Jin Y, Xie JL, Wei XJ, Chen SY, Mei X, Gong LP, Lü BB.

Zhonghua Bing Li Xue Za Zhi. 2011 Apr;40(4):227-34. Chinese.

PMID:
21615995
[PubMed - indexed for MEDLINE]
18.

An extranodal nasal natural killer/T-cell lymphoma with isochromosome 7q10 as the sole cytogenetic aberration was initially diagnosed via bone marrow biopsy.

Wang HY, Wilson KS, McKenna RW, Xu Y, Karandikar N.

Arch Pathol Lab Med. 2007 Nov;131(11):1709-14.

PMID:
17979491
[PubMed - indexed for MEDLINE]
19.

Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK.

Child FJ, Mitchell TJ, Whittaker SJ, Calonje E, Spittle M, Crocker J, Russell-Jones R.

Br J Dermatol. 2003 Mar;148(3):507-15.

PMID:
12653743
[PubMed - indexed for MEDLINE]
20.

Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.

Magro F, Portela F.

BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. Review.

PMID:
21175228
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk